NASDAQ:INCY • US45337C1027
This INCY fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
INCY gets a fundamental rating of 7 out of 10. The analysis compared the fundamentals against 519 industry peers in the Biotechnology industry. INCY gets an excellent profitability rating and is at the same time showing great financial health properties. A decent growth rate in combination with a cheap valuation! Better keep an eye on INCY. These ratings could make INCY a good candidate for value and quality investing.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.49% | ||
| ROE | 24.9% | ||
| ROIC | 19.49% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.12% | ||
| PM (TTM) | 25.03% | ||
| GM | 93.26% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Altman-Z | 8.16 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.32 | ||
| Quick Ratio | 3.25 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 11.94 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 13.43 | ||
| EV/EBITDA | 9.95 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NASDAQ:INCY (3/13/2026, 11:58:37 AM)
91.425
-0.61 (-0.66%)
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 13.46 | ||
| Fwd PE | 11.94 | ||
| P/S | 3.54 | ||
| P/FCF | 13.43 | ||
| P/OCF | 12.87 | ||
| P/B | 3.52 | ||
| P/tB | 3.7 | ||
| EV/EBITDA | 9.95 |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 18.49% | ||
| ROE | 24.9% | ||
| ROCE | 24.67% | ||
| ROIC | 19.49% | ||
| ROICexc | 56.96% | ||
| ROICexgc | 65.8% | ||
| OM | 26.12% | ||
| PM (TTM) | 25.03% | ||
| GM | 93.26% | ||
| FCFM | 26.35% |
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Debt/EBITDA | 0.02 | ||
| Cap/Depr | 63.1% | ||
| Cap/Sales | 1.15% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 98.43% | ||
| Profit Quality | 105.28% | ||
| Current Ratio | 3.32 | ||
| Quick Ratio | 3.25 | ||
| Altman-Z | 8.16 |
ChartMill assigns a fundamental rating of 7 / 10 to INCY.
ChartMill assigns a valuation rating of 7 / 10 to INCYTE CORP (INCY). This can be considered as Undervalued.
INCYTE CORP (INCY) has a profitability rating of 9 / 10.
The financial health rating of INCYTE CORP (INCY) is 7 / 10.
The Earnings per Share (EPS) of INCYTE CORP (INCY) is expected to grow by 12.8% in the next year.